Premium
PREGNANCY FOLLOWING BROMOCRYPTINE THERAPY FOR THE AMENORRHOEA–GALACTORRHOEA SYNDROME DUE TO A PITUITARY TUMOUR
Author(s) -
PerryKeene D. A.,
Warne G. L.,
Martin F. I. R.
Publication year - 1976
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1976.tb115269.x
Subject(s) - hyperprolactinaemia , medicine , pregnancy , menstruation , amenorrhea , pituitary disorder , bromocriptine , obstetrics , gynecology , prolactin , hormone , biology , genetics
A woman developed amenorrhoea and galactorrhoea after partial removal of a pituitary tumour during pregnancy. Hyperprolactinaemia was suppressed by therapy with bromocryptine (CB 154, Sandoz) resulting in cessation of galactorrhoea in two months, spontaneous menstruation after eight months, and pregnancy after twelve months.